Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on May 9, 2013
Ben Philpot of the University of North Carolina at Chapel Hill discusses his project to screen for compounds that can reactivate the silenced MECP2 gene as a treatment for Rett Syndrome. He also discusses his Angelman Syndrome project. This project is being supported by the Rett Syndrome Research Trust with a $2.2 million award.
This presentation was videotaped in NYC on April 23, 2013.
The Rett Syndrome Research Trust is a non-profit exclusively devoted to global research on Rett Syndrome and related MECP2 disorders. Our goal is to heal children and adults who will otherwise suffer the effects of these disorders for the rest of their lives. Subscribe for updates on Rett Syndrome and The Rett Syndrome Research Trust at http://bit.ly/reverserett